Skip to main content
. 2022 Mar 15;11:e69798. doi: 10.7554/eLife.69798

Table 2. The pharmacokinetics of Tebipenem and Tebipenem pivoxil.

Value Mice Piglets Paediatric population (Sato et al., 2008)
Tebipenem SQ (n = 3) Tebipenem PO(n = 3) Tebipenem-Pivoxil PO(n = 3) Tebipenem-Pivoxil PO(n = 2) Tebipenem-Pivoxil PO
Cmax (µg/ml) 71.0 ± 15.3 3.7 ± 0.9 61.6 ± 3.9 9.0 ± 0.8 7.5 ± 3.9
Tmax [Range] (hr) [0.25 0.25] [0.5 1] [0.25 0.5] [2 2] 0.7 ± 0.2
AUC0-tlast (hr*µg/mL) 80.4 ± 7.7 7.5 ± 1.5 93.8 ± 2.7 32.6 ± 3.9 16.1 ± 3.3
Bioavailability (%) 44 ± 4 4 ± 1 52 ± 1 ND ND